Polomar Health Services (PMHS) Current Assets (2022 - 2026)
Polomar Health Services (PMHS) posted Current Assets of $781250.0 for Q2 2026, up 67.06% on a QoQ basis from $467650.0 in Q1 2026, and up 739.57% year-over-year from $93054.0 in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) Current Assets (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Current Assets for 5 years, with the latest figure at $781250.0 in Q2 2026.
- On a quarterly basis, Current Assets rose 739.57% year-over-year to $781250.0 in Q2 2026; TTM through Jun 2026 was $781250.0, a 739.57% increase from a year earlier, with the FY2025 full-year figure at $322727.0, up 320.15% from the prior year.
- Current Assets was $781250.0 for Q2 2026 at Polomar Health Services, up from $467650.0 in the prior quarter.
- The five-year high for Current Assets was $781250.0 in Q2 2026, with the low at $244.0 in Q1 2024.
- Average Current Assets over 5 years is $202138.7, with a median of $143164.5 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Current Assets sank 99.77% in 2024, then surged 82359.02% in 2025.
- Over 5 years, Current Assets stood at $261484.0 in 2022, then plunged by 95.31% to $12267.0 in 2023, then jumped by 526.18% to $76813.0 in 2024, then soared by 320.15% to $322727.0 in 2025, then surged by 142.08% to $781250.0 in 2026.
- The last three Current Assets figures came in at $781250.0 (Q2 2026), $467650.0 (Q1 2026), and $322727.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 13.76 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 10.06 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.16 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.95 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 6.52 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 825.43 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 544.97 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 630.95 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 72.50 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 781,250.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 781,250.00 |
| Mar 31, 2026 | 467,650.00 |
| Dec 31, 2025 | 322,727.00 |
| Sep 30, 2025 | 197,664.00 |
| Jun 30, 2025 | 93,054.00 |
| Mar 31, 2025 | 201,200.00 |
| Dec 31, 2024 | 76,813.00 |
| Sep 30, 2024 | 156,105.00 |
| Jun 30, 2024 | 294.00 |
| Mar 31, 2024 | 244.00 |
| Dec 31, 2023 | 12,267.00 |
| Sep 30, 2023 | 128,966.00 |
| Jun 30, 2023 | 130,224.00 |
| Dec 31, 2022 | 261,484.00 |